ENLIVEN THERAPEUTICS INC

Ticker: ELVN CUSIP: 29337E102 Class: Common Stock

PRELUDE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001387508)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 52,578 Value ($000) $810 Avg Close $19.92 Range $15.14 - $24.64

Q1 2024

Shares 12,484 Value ($000) $220 Avg Close $15.34 Range $10.90 - $19.50

Q2 2023

Shares 33,550 Value ($000) $27 Avg Close $20.21 Range $17.15 - $23.98

Q1 2023

Shares 34,062 Value ($000) $40 Avg Close $20.34 Range $14.56 - $25.34

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	52,578	$810	$19.92	$15.14 - $24.64
Q1 2024	12,484	$220	$15.34	$10.90 - $19.50
Q2 2023	33,550	$27	$20.21	$17.15 - $23.98
Q1 2023	34,062	$40	$20.34	$14.56 - $25.34